Dendritic cell vaccination in acute myeloid leukemia

By Anguille Sébastien   Willemen Yannick   Lion Eva   Smits Evelien L.   Berneman Zwi N.  

Cytotherapy, Vol. 14, Iss. 6, 2012-07 ,pp. : 647-656

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission

By Linn Yeh-Ching   Yong Hao-Xiang   Niam Madelaine   Lim Tsyr-Jong   Chu Sixian   Choong Alicia   Chuah Charles   Goh Yeow-Tee   Hwang William   Loh Yvonne   Ng Heng-Joo   Suck Garnet   Chan Marieta   Koh Mickey  

Cytotherapy, Vol. 14, Iss. 7, 2012-08 ,pp. : 851-859

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Transplantation of allogeneic CD34 + -selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia

By Kobbe G   Fenk R   Neumann F   Bernhardt A   Steidl U   Kondakci M   Graef T   Aivado M   Vaupel M   Huenerlituerkoglu A-N   Kronenwett R   Pape H   Hildebrand B   Germing U   Haas R  

Cytotherapy, Vol. 6, Iss. 6, 2004-12 ,pp. : 533-542

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia

By  

Cytometry. Part B: Clinical Cytometry, Vol. 94, Iss. 1, 2018-01 ,pp. : 151-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Visceral Leishmaniasis in a Case of Acute Lymphoblastic Leukemia at Both Remission and Relapse, Diagnosed by Bone Marrow Aspiration

By  

Acta Cytologica, Vol. 54, Iss. 5, 2011-02 ,pp. : 743-746

Karger

Access to resources Recommend Favorite